[HTML][HTML] Engineering nanoparticle toolkits for mRNA delivery
The concept of using mRNA to produce its own medicine in situ in the body makes it an ideal
drug candidate, holding great potential to revolutionize the way we approach medicine. The …
drug candidate, holding great potential to revolutionize the way we approach medicine. The …
Advances in the treatment of atherosclerosis with ligand‐modified nanocarriers
X Deng, J Wang, S Yu, S Tan, T Yu, Q Xu, N Chen… - …, 2024 - Wiley Online Library
Atherosclerosis, a chronic disease associated with metabolism, poses a significant risk to
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …
human well‐being. Currently, existing treatments for atherosclerosis lack sufficient efficiency …
Applications and strategies in nanodiagnosis and nanotherapy in lung cancer
Lung cancer is the second most common cancer and the leading cause of death in both men
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …
and women in the world. Lung cancer is heterogeneous in nature and diagnosis is often at …
Nanoplatforms for mRNA therapeutics
C Meng, Z Chen, G Li, T Welte… - Advanced Therapeutics, 2021 - Wiley Online Library
Abstract mRNA‐based therapeutics are a unique class of drugs for treatment of human
diseases. Since in vitro transcribed mRNA molecules have relatively low stability and their …
diseases. Since in vitro transcribed mRNA molecules have relatively low stability and their …
[HTML][HTML] Engineering poly-and micelleplexes for nucleic acid delivery–A reflection on their endosomal escape
B Winkeljann, DC Keul, OM Merkel - Journal of Controlled Release, 2023 - Elsevier
For the longest time, the field of nucleic acid delivery has remained skeptical whether or not
polycationic drug carrier systems would ever make it into clinical practice. Yet, with the …
polycationic drug carrier systems would ever make it into clinical practice. Yet, with the …
Overcoming barriers in non-viral gene delivery for neurological applications
A Tasset, A Bellamkonda, W Wang, I Pyatnitskiy… - Nanoscale, 2022 - pubs.rsc.org
Gene therapy for neurological disorders has attracted significant interest as a way to reverse
or stop various disease pathologies. Typical gene therapies involving the central and …
or stop various disease pathologies. Typical gene therapies involving the central and …
Delivery of Anti‐microRNA‐712 to Inflamed Endothelial Cells Using Poly(β‐amino ester) Nanoparticles Conjugated with VCAM‐1 Targeting Peptide
Endothelial cells (ECs) are an important target for therapy in a wide range of diseases, most
notably atherosclerosis. Develo** efficient nanoparticle (NP) systems that deliver RNA …
notably atherosclerosis. Develo** efficient nanoparticle (NP) systems that deliver RNA …
Polycation-mediated transfection: Mechanisms of internalization and intracellular trafficking
BD Monnery - Biomacromolecules, 2021 - ACS Publications
Polyplex-mediated gene transfection is now in its' fourth decade of serious research, but the
promise of polyplex-mediated gene therapy has yet to fully materialize. Only approximately …
promise of polyplex-mediated gene therapy has yet to fully materialize. Only approximately …
Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy in vivo
W Men, P Zhu, S Dong, W Liu, K Zhou, Y Bai, X Liu… - Drug …, 2020 - Taylor & Francis
In this work, a pH-sensitive liposome–polymer nanoparticle (NP) composed of lipid,
hyaluronic acid (HA) and poly (β-amino ester)(PBAE) was prepared using layer-by-layer …
hyaluronic acid (HA) and poly (β-amino ester)(PBAE) was prepared using layer-by-layer …
On complex coacervate core micelles: Structure-function perspectives
The co-assembly of ionic-neutral block copolymers with oppositely charged species
produces nanometric colloidal complexes, known, among other names, as complex …
produces nanometric colloidal complexes, known, among other names, as complex …